These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Management and Outcomes for Neovascular Age-Related Macular Degeneration: Analysis of United States Electronic Health Records. Kiss S; Campbell J; Almony A; Shih V; Serbin M; LaPrise A; Wykoff CC Ophthalmology; 2020 Sep; 127(9):1179-1188. PubMed ID: 32345477 [TBL] [Abstract][Full Text] [Related]
11. Intravitreal anti-vascular endothelial growth factor for typical exudative age-related macular degeneration in eyes with good baseline visual acuity. Chang YS; Han JI; Yoo SJ; Lew YJ; Kim JH Korean J Ophthalmol; 2014 Dec; 28(6):466-72. PubMed ID: 25435749 [TBL] [Abstract][Full Text] [Related]
15. Detailed Evaluation of Chromatic Pupillometry and Full-Field Stimulus Testing to Assess Ultralow Vision in Retinitis Pigmentosa. Yamamoto M; Matsuyama T; Maeda T; Takagi S; Motozawa N; Sakai D; Hirami Y; Maeda A; Kurimoto Y; Takahashi M; Mandai M Ophthalmol Sci; 2023 Dec; 3(4):100328. PubMed ID: 37920419 [TBL] [Abstract][Full Text] [Related]
16. TEN-YEAR FOLLOW-UP OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS. Starr MR; Kung FF; Mejia CA; Bui YT; Bakri SJ Retina; 2020 Sep; 40(9):1665-1672. PubMed ID: 31725524 [TBL] [Abstract][Full Text] [Related]
17. Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema. Zehetner C; Kirchmair R; Huber S; Kralinger MT; Kieselbach GF Br J Ophthalmol; 2013 Apr; 97(4):454-9. PubMed ID: 23385630 [TBL] [Abstract][Full Text] [Related]
18. Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A Real-World Analysis of 49 485 Eyes. Ciulla TA; Hussain RM; Pollack JS; Williams DF Ophthalmol Retina; 2020 Jan; 4(1):19-30. PubMed ID: 31324588 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization. Kim JH; Chang YS; Kim JW; Kim CG; Yoo SJ; Cho HJ Ophthalmology; 2014 Apr; 121(4):926-35. PubMed ID: 24342019 [TBL] [Abstract][Full Text] [Related]
20. Effect of Alternate Treatment with Intravitreal Anti-Vascular Endothelial Growth Factor and Steroid for Treatment-Naive Diabetic Macular Edema in a Real-Life Setting. Lee JY; Lee SY; Kim JY; Lee HJ; Jeong JH; Ma DJ J Ocul Pharmacol Ther; 2020 Sep; 36(7):555-562. PubMed ID: 32397788 [No Abstract] [Full Text] [Related] [Next] [New Search]